OBJECTIVE: Several case reports and retrospective studies have reported a temporal association between red blood cell (RBC) transfusions and necrotizing enterocolitis (NEC). In this article, we review the clinical evidence and biological plausibility of the association between RBC transfusions and NEC. METHODS: A literature search was performed using the databases PubMed, EMBASE, and Scopus, and the electronic archive of abstracts presented at the annual meetings of the Pediatric Academic Societies. RESULTS: Among all cases of NEC, 25 -40% patients were noted to have received an RBC transfusion within a 48 hour period prior to onset of NEC. Compared to infants who developed NEC unrelated to transfusion, neonates with transfusion-associated NEC were born at an earlier gestation, had lower birth weights, and had a delayed onset at 3-5 weeks of postnatal age. CONCLUSIONS: Based on current clinical evidence, transfusion-associated NEC appears to be a plausible clinical entity. However, there is a need for cautious interpretation of data because all the studies that have been conducted until date are retrospective, and therefore, susceptible to bias. A large, prospective, multi-center trial is needed to evaluate the association between RBC transfusion and NEC.
OBJECTIVE: Several case reports and retrospective studies have reported a temporal association between red blood cell (RBC) transfusions and necrotizing enterocolitis (NEC). In this article, we review the clinical evidence and biological plausibility of the association between RBC transfusions and NEC. METHODS: A literature search was performed using the databases PubMed, EMBASE, and Scopus, and the electronic archive of abstracts presented at the annual meetings of the Pediatric Academic Societies. RESULTS: Among all cases of NEC, 25 -40% patients were noted to have received an RBC transfusion within a 48 hour period prior to onset of NEC. Compared to infants who developed NEC unrelated to transfusion, neonates with transfusion-associated NEC were born at an earlier gestation, had lower birth weights, and had a delayed onset at 3-5 weeks of postnatal age. CONCLUSIONS: Based on current clinical evidence, transfusion-associated NEC appears to be a plausible clinical entity. However, there is a need for cautious interpretation of data because all the studies that have been conducted until date are retrospective, and therefore, susceptible to bias. A large, prospective, multi-center trial is needed to evaluate the association between RBC transfusion and NEC.
Authors: N Hall; E G p Ong; N Ade-Ajayi; L Fasoli; M Ververidis; E M Kiely; D P Drake; L Spitz; I Hann; Q Mok; A Pierro Journal: J Pediatr Surg Date: 2002-05 Impact factor: 2.545
Authors: T T B Ho; M W Groer; A A Luciano; A Schwartz; M Ji; B S Miladinovic; A Maheshwari; T L Ashmeade Journal: J Perinatol Date: 2015-07-16 Impact factor: 2.521
Authors: Jayasree Nair; Sylvia F Gugino; Lori C Nielsen; Cheryl Allen; James A Russell; Bobby Mathew; Daniel D Swartz; Satyan Lakshminrusimha Journal: Pediatr Res Date: 2013-09-03 Impact factor: 3.756
Authors: Minesh Khashu; Christof Dame; Pascal M Lavoie; Isabelle G De Plaen; Parvesh M Garg; Venkatesh Sampath; Atul Malhotra; Michael D Caplan; Praveen Kumar; Pankaj B Agrawal; Giuseppe Buonocore; Robert D Christensen; Akhil Maheshwari Journal: Newborn (Clarksville) Date: 2022-03-31
Authors: I Martynov; W Göpel; T K Rausch; C Härtel; A Franke; A R Franz; D Viemann; U H Thome; M Lacher; B W Ackermann Journal: Sci Rep Date: 2021-07-02 Impact factor: 4.379
Authors: C L Ellis; N A Bokulich; K M Kalanetra; M Mirmiran; J Elumalai; L Haapanen; T Schegg; J C Rutledge; G Raff; D A Mills; M A Underwood Journal: J Perinatol Date: 2013-04-18 Impact factor: 2.521